Metraipolis › archive › dc_53ba08e205f6

Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status — Europe PMC PMID:42732414

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42732414
DOI
10.7759/cureus.114472
License (as archived)
solo-consultazione
Archived
2026-10-16T20:21:56.707Z
SHA-256 of the archived text
be696522632110c1400350de9bf428e64bea45df6e43b769e5de7ffcce3bf59f
Stable URL of this page
https://metraipolis.com/documento/dc_53ba08e205f6

How to cite

Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status — Europe PMC PMID:42732414 — Europe PMC (en), https://europepmc.org/article/MED/42732414 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_53ba08e205f6 (Metraipolis archive dc_53ba08e205f6, sha256 be696522632110c1400350de9bf428e64bea45df6e43b769e5de7ffcce3bf59f)
BibTeX
@misc{dc53ba08e205f6,
  title = {Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status — Europe PMC PMID:42732414},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42732414},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_53ba08e205f6; sha256 be696522632110c1400350de9bf428e64bea45df6e43b769e5de7ffcce3bf59f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42732414. Agents can read the archived copy with the MCP tool read_document.